Donna Culton, MD, University of North Carolina at Chapel Hill, outlines diagnosing autoimmune blistering diseases.
Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...
Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATE ...
The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...
Acne, allergies, and infections are some of the most common causes of red dots on your skin. Red dots on your skin that occur with breathing difficulties and wheezing require medical attention right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results